OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2019
(4)
2025
(2)
2022
(2)
2018
(2)
2021
(1)
2020
(1)
2016
(1)
2015
(1)
2014
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Network abnormalities among non-manifesting Parkinson disease related LRRK2 mutation carriers.
Not available
S-EPMC6865680
|
biostudies-literature
Cite
Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry.
Not available
S-EPMC6128247
|
biostudies-literature
Cite
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF.
Not available
S-EPMC10132447
|
biostudies-literature
Cite
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.
Not available
S-EPMC2970549
|
biostudies-literature
Cite
Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes.
Not available
S-EPMC6707204
|
biostudies-literature
Cite
SPARK: A US Cohort of 50,000 Families to Accelerate Autism Research.
Not available
S-EPMC7444276
|
biostudies-literature
Cite
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders.
Not available
S-EPMC7530681
|
biostudies-literature
Cite
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618
|
biostudies-literature
Cite
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
Not available
S-EPMC8248139
|
biostudies-literature
Cite
Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes.
Not available
S-EPMC9470534
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets